Metsa XR 1000 mg (Tablet (Extended Release))

Unit Price: ৳ 9.00 (3 x 10: ৳ 270.00)
Strip Price: ৳ 90.00

Medicine Details

Indications

  • Treatment of type 2 diabetes mellitus in adults
  • Treatment of type 2 diabetes mellitus in children from 10 years of age and adolescents
  • Reduction of diabetic complications in overweight type 2 diabetic adult patients

Pharmacology

  • Biguanide type oral antihyperglycemic drug
  • Lowers basal and postprandial plasma glucose
  • Decreases hepatic glucose production
  • Decreases intestinal absorption of glucose
  • Improves insulin sensitivity

Dosage & Administration

  • Individualized dosage based on effectiveness and tolerance
  • Usual starting dose of 500 mg twice a day for adults
  • Usual starting dose of 500 mg twice a day for children
  • Recommended dosage increases for adults and children
  • Maximum recommended daily doses for adults and children
  • Instructions for Metformin extended release tablet

Interaction

  • No information available about the chronic co-administration with Furosemide
  • Nifedipine appears to enhance the absorption of Metsa XR
  • Potential interaction with cationic drugs and renal tubular transport systems
  • Minimal effects on Cimetidine pharmacokinetics
  • Drugs that tend to produce hyperglycemia and may lead to loss of glycemic control

Contraindications

  • Hypersensitivity to the active substance or excipients
  • Acute metabolic acidosis
  • Severe renal failure
  • Acute conditions with potential to alter renal function
  • Conditions causing tissue hypoxia

Side Effects

  • Hemolytic anemia
  • Lactic acidosis
  • Decrease of vitamin B12 absorption
  • Peripheral neuropathy in patients with vitamin B12 deficiency
  • Taste disturbance
  • Encephalopathy
  • Gastrointestinal disorders
  • Liver function test abnormalities or hepatitis
  • Skin reactions

Pregnancy & Lactation

  • Uncontrolled diabetes during pregnancy associated with increased risk of congenital abnormalities and perinatal mortality
  • Recommendation to use insulin instead of metformin during pregnancy
  • Excretion of Metformin into human breast milk
  • No adverse effects observed in breastfed newborns/infants

Precautions & Warnings

  • Substantial excretion by the kidney
  • Decrease in vitamin B12 level
  • Increased risk of hypoglycemia when used in combination with insulin
  • Regular monitoring of renal function
  • Cautious use in conditions causing dehydration, serious infections, or trauma
  • Annual estimation of Vitamin B-12 levels
  • Cautious use with sulphonylurea and concomitant therapy with insulin
  • Interaction with cimetidine and anticoagulants

Use in Special Populations

  • Adjustment of metformin dosage based on renal function in elderly subjects
  • Regular assessment of renal function in elderly
  • Recommendation for careful follow-up of effect on growth and puberty in metformin-treated children
  • Particular caution recommended in prescribing to children aged between 10 and 12 years
  • Creatinine clearance determination before initiating treatment
  • Regular GFR assessment before and during treatment

Overdose Effects

  • Hypoglycemia not seen at doses up to 85 gm
  • Lactic acidosis occurred in such circumstances
  • Treatment involves hospital care

Therapeutic Class

  • Biguanides

Storage Conditions

  • Keep below 30°C temperature
  • Protected from light & moisture
  • Keep out of the reach of children

Related Brands